MAOA and serotonin syndrome: Drug-drug interactions can occur with serotonergic and adrenergic agents due to linezolid being a weak, non-selective, reversible inhibitor of monoamine oxidase A and B. A review of serotonergic interactions with linezolid found the incidence of serotonin syndrome was 0.24% to 4% [20].